Litcius/Paper detail

ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia

Wilfried Posch, Jonathan Vosper, Viktoria Zaderer, Asma Noureen, Samuel Constant, Rosa Bellmann‐Weiler, Cornelia Lass‐Flörl, Doris Wilflingseder

2021mBio24 citationsDOIOpen Access PDF

Abstract

Although our understanding of COVID-19 continuously progresses, essential questions regarding prophylaxis and treatment remain open. A hallmark of severe SARS-CoV-2 infection is a hitherto-undescribed mechanism leading to excessive inflammation and tissue destruction associated with enhanced pathogenicity and mortality.

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Sars virusAirway2019-20 coronavirus outbreakVirologyBetacoronavirusBiologyMedicinePathologyOutbreakAnesthesiaInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingInhalation and Respiratory Drug Delivery